Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
3417294
Title:
PROCÉDÉS COMPRENANT UN DOSAGE INTERMITTENT ET FIXE DE CEDIRANIB
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
177537040
WO application number:
US2017017804
Type:
European patent granted for BE
Status:
Open
Publication number:
3417294
WO publication number:
WO2017142871
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
14/02/2017
Grant date:
01/12/2021
EP publication date:
26/12/2018
WO publication date:
24/08/2017
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
01/12/2021
EP B1 publication date:
01/12/2021
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
14/02/2037
Applicant
1
Name:
Astrazeneca AB
Legal Form:
From:
01/12/2021
Address:
151 85 Södertälje, Sweden (SE)
To:
2
Name:
The United States of America, as Represented By the Secretary, Department of Health and Human Services
Legal Form:
From:
08/03/2022
Address:
National Institutes of Health
Office of Technology Transfer
6701 Rockledge Drive
Suite 700, MSC 7788, Bethesda, MD 20892, United States (US)
To:
Agent
1
Name:
AWA Benelux SA
Legal Form:
From:
27/02/2023
Address:
Tour & Taxis - Royal Depot box: 216
Avenue du Port 86c, 1000, BRUXELLES, Belgium (BE)
To:
2
Name:
AWA Benelux SA
Legal Form:
From:
15/02/2022
Address:
Tour & Taxis - Royal Depot box: 216
Avenue du Port 86c, 1000, BRUXELLES, Belgium (BE)
To:
27/02/2023
Inventor
1
Name:
BARRY, Simon
Legal Form:
Address:
Cambridge CB4 0WG, United Kingdom (GB)
2
Name:
KENDREW, Jane
Legal Form:
Address:
Macclesfield
Cheshire SK10 4TG, United Kingdom (GB)
3
Name:
HO, Tony
Legal Form:
Address:
Gaithersburg, MD 20878, United States (US)
4
Name:
WEDGE, Stephen, Robert
Legal Form:
Address:
Granta Park
Cambridge CB21 6GH, United Kingdom (GB)